BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1395561)

  • 21. Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice.
    Atarashi K; Kabashima K; Akiyama K; Tokura Y
    Br J Dermatol; 2008 Aug; 159(2):306-13. PubMed ID: 18565185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of coal tar on cignolin erythema--1 hour treatment of psoriasis with high-dose cignolin with and without tar].
    Schauder S; Mahrle G
    Z Hautkr; 1985 Jun; 60(11):875-83. PubMed ID: 3160177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ABC of dermatology. Treatment of psoriasis.
    Going SM
    Br Med J (Clin Res Ed); 1987 Oct; 295(6604):984-6. PubMed ID: 3119131
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of ultraviolet irradiation on surface marker expression by epidermal immunocompetent cells and contact sensitization to dinitrofluorobenzene in mice.
    Orita M
    Br J Dermatol; 1987 Dec; 117(6):721-33. PubMed ID: 3480755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pentamidine isethionate reduces Ia expression and antigen presentation by Langerhans cells and inhibits the contact hypersensitivity reaction.
    Blaylock BL; Kouchi Y; Comment CE; Corsini E; Rosenthal GJ; Luster MI
    J Immunol; 1991 Oct; 147(7):2116-21. PubMed ID: 1833452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-contact dithranol therapy--a comparison with the Ingram regime.
    Statham BN; Ryatt KS; Rowell NR
    Br J Dermatol; 1984 Jun; 110(6):703-8. PubMed ID: 6733040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strain variation in the induction of tolerance by epicutaneous application of trinitrochlorobenzene.
    Sauder DN; Katz SI
    J Invest Dermatol; 1983 May; 80(5):383-6. PubMed ID: 6221052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis.
    Morison WL; Parrish JA; Fitzpatrick TB
    Br J Dermatol; 1978 Feb; 98(2):125-32. PubMed ID: 629867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical agents for the treatment of psoriasis, past, present and future.
    Tremblay JF; Bissonnette R
    J Cutan Med Surg; 2002; 6(3 Suppl):8-11. PubMed ID: 11976984
    [No Abstract]   [Full Text] [Related]  

  • 30. Topical application of T-2 toxin inhibits the contact hypersensitivity response in BALB/c mice.
    Blaylock BL; Kouchi Y; Comment CE; Pollock PL; Luster MI
    J Immunol; 1993 Jun; 150(11):5135-43. PubMed ID: 8496607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of glucocorticosteroids on epidermal Langerhans cells.
    Belsito DV; Flotte TJ; Lim HW; Baer RL; Thorbecke GJ; Gigli I
    J Exp Med; 1982 Jan; 155(1):291-302. PubMed ID: 6459400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATPase, antigens detected by monoclonal antibodies, ultrastructural characters: which is the best marker for Langerhans cells?
    De Panfilis G
    Arch Dermatol Res; 1983; 275(6):407-11. PubMed ID: 6229220
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of local PUVA on epidermal Langerhans' cells in guinea pigs].
    Chen HD
    Zhonghua Yi Xue Za Zhi; 1986 Nov; 66(11):668-70. PubMed ID: 3102011
    [No Abstract]   [Full Text] [Related]  

  • 34. Involvement of NO in contact hypersensitivity.
    Ross R; Gillitzer C; Kleinz R; Schwing J; Kleinert H; Förstermann U; Reske-Kunz AB
    Int Immunol; 1998 Jan; 10(1):61-9. PubMed ID: 9488156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of topical corticosteroids and a coal tar preparation on dithranol-induced irritation in patients with psoriasis.
    Swinkels OQ; Kucharekova M; Prins M; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 2003; 16(1):12-7. PubMed ID: 12566824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pustulosis palmoplantaris and chronic eczematous hand dermatitis. Treatment, epidermal Langerhans cells and association with thyroid disease.
    Rosén K
    Acta Derm Venereol Suppl (Stockh); 1988; 137():1-52. PubMed ID: 3285630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The epidermal Langerhans' cell population in psoriasis during topical coal tar therapy.
    Puttick LM; Johnson GD; Walker L
    Acta Derm Venereol; 1986; 66(4):343-6. PubMed ID: 2430408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psoriasis: current advances in etiology and treatment.
    Cram DL
    J Am Acad Dermatol; 1981 Jan; 4(1):1-14. PubMed ID: 7009659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contact hypersensitivity in MHC class II-deficient mice depends on CD8 T lymphocytes primed by immunostimulating Langerhans cells.
    Bouloc A; Cavani A; Katz SI
    J Invest Dermatol; 1998 Jul; 111(1):44-9. PubMed ID: 9665385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal Langerhans' cells in chronic eczematous dermatitis of the palms treated with PUVA and UVB.
    Rosén K; Jontell M; Mobacken H; Rosdahl I
    Acta Derm Venereol; 1989; 69(3):200-5. PubMed ID: 2566222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.